New combo therapy aims to slash deadly leaks after pancreatic cancer surgery
NCT ID NCT07262957
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests whether giving three treatments together—two medicines and a surgical patch—can lower the risk of major complications after Whipple surgery for pancreatic cancer and other tumors. The study includes 400 high-risk patients with a small pancreatic duct. If successful, this approach could become a new standard to help patients recover faster and avoid life-threatening leaks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMPULLA OF VATER ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Amsterdam UMC
RECRUITINGAmsterdam, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new ultrasound technique spot hidden pancreatic cancers earlier?
- Can a smart drug home in on Hard-to-Treat GI cancers?
- Could a simple blood test catch pancreatic cancer before It's too late?
- Could a common diabetes drug boost chemotherapy against pancreatic cancer?
- Could a simple phosphate IV ease severe pancreatitis?
- Scientists hunt for clues to prevent a common complication after pancreatic cancer surgery